menu
    • menu

    Company profile for Adalvo

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Adalvo is a global pharmaceutical company with a declared purpose to make a difference for patients around the world driven by our smart collaboration network and commitment to deliver highest quality differentiated products and services to our partners. Our business is fueled by our passion for relentless commitment to the customer network we serve. No half measures - we are always on target.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AdalvoMalta Flag
    Country
    Country
    Malta
    Address
    Address
    Level 4, Sir Temi Zammit Buildings, Malta Life Sciences Park, San Gwann SGN30...
    Telephone
    Telephone
    +356 22485944
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.adalvo.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alvotech Restructures Global Biz Development and Commercial Team
    Alvotech Restructures Global Biz Development and Commercial Team

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170858/0/en/Alvotech-Announces-Changes-in-Global-Business-Development-and-Commercial-Operations-Team.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    EQT to Acquire Adalvo, a Leading B2B Dossier Developer
    EQT to Acquire Adalvo, a Leading B2B Dossier Developer

    19 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eqt-to-acquire-adalvo-a-leading-b2b-dossier-developer-302508580.html

    PR NEWSWIRE
    19 Jul 2025
    Share Share
    Formosa, Adalvo License Clobetasol For Eye Conditions
    Formosa, Adalvo License Clobetasol For Eye Conditions

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-adalvo-limited-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-ocular-inflammation-and-pain-302465602.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    CNX Therapeutics and Adalvo Announce Nitrofurantoin PR Agreement
    CNX Therapeutics and Adalvo Announce Nitrofurantoin PR Agreement

    16 Dec 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-12-16/cnx-therapeutics-and-adalvo-announce-strategic-agreement-for-commercialisation-of-nitrofurantoin-pr

    PHARMAWEB
    16 Dec 2024
    Share Share
    Adalvo Receives European Approval for Liraglutide Pen
    Adalvo Receives European Approval for Liraglutide Pen

    17 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169773&sid=2

    PHARMABIZ
    17 Jun 2024
    Share Share
    Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen
    Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen

    13 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/13/2898123/0/en/Adalvo-Secures-First-EU-Generic-Approval-for-Liraglutide-Pre-Filled-Pen.html

    GLOBENEWSWIRE
    13 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search